Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany: First results from the prospective German Registry CRISP (AIO-TRK-0315).

• DOI: 10.1200/jco.2018.36.15_suppl.e21236
• Publication Date: 2018-09-05T14:47:58Z
• Authors: Frank Griesinger; Wilfried Ernst Er...; Arnd Nusch; Marcel Reiser; Mark-Oliver Zahn; Norbert Walter Ma...; Martina Jänicke; Annette Fleitz; Lisa Spring; Joerg Sahlmann; Aysun Karatas; Annette Hipper; Wilko Weichert; Achim Rittmeyer; Martin Metzenmacher; Cornelius F. Waller; Martin Sebastian; Michael Thomas
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Medizin; 3. Good health

e21236Background: Treatment in non-small cell lung cancer is quickly evolving and new agents make it to the routine practice at a rapid pace. It is of high interest to patients (pts), physicians an...